Neurona Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Lifesciences Conference

SAN FRANCISCO, Feb. 07, 2024 (GLOBE NEWSWIRE) — Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s chief executive officer, will provide a corporate update at the Oppenheimer 34th Annual Healthcare Lifesciences Conference on Wednesday, February 14 at 2:00 pm ET. The presentation will be webcast live and may be accessed via a link in the News section of the Neurona website under Events. An archived copy of the webcast will be available on the website for approximately 30 days after the event. About Neurona TherapeuticsNeurona is focused on developing regenerative cell therapy candidates with single-dose curative potential. Neurona’s investigational allogeneic, off-the-shelf, cell therapy candidates are designed to provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona, visit www.neuronatherapeutics.com. Investor and Media Contacts: Sylvia WheelerWheelhouse [email protected] Wolffe, Ph.D.Wheelhouse [email protected]